- Research Article
- 10.71152/ajms.v17i3.5055
Dynamics of lipid profile across clinical phases of pediatric idiopathic nephrotic syndrome: An observational study in a tertiary care setting
- Mar 01, 2026
- Asian Journal of Medical Sciences
- Prativa Biswas + 7 more +7
Background: Nephrotic syndrome (NS) is a chronic kidney disorder characterized by significant metabolic disturbances, including dyslipidemia, hypoalbuminemia, and proteinuria, which contribute to disease progression and increased risk of relapse. Aims and Objectives: This study aims to analyze the biochemical and clinical variations in pediatric NS across different disease phases and assess their implications for disease prognosis and management. Materials and Methods: This is a hospital-based longitudinal observational study conducted to assess lipid profile alterations in 1–12-year-old pediatric patients diagnosed with idiopathic NS during the first episode, remission, and relapse. A comprehensive statistical analysis was performed to evaluate clinical and biochemical parameters in children with NS across three phases: first episode, relapse, and remission. Analysis of variance and post hoc comparisons were applied to identify significant differences in lipid profile (total cholesterol, high-density lipoprotein [HDL], low-density lipoprotein [LDL], very LDL, triglycerides), serum albumin, total protein, creatinine, and 24-h urine protein excretion. Statistical analysis was performed by the Statistical Package for the Social Sciences version 24. Significance levels were denoted as P≤0.05. Results: The study found significant differences in lipid profile parameters during relapse, with high levels of total cholesterol, LDL, and triglycerides and declining HDL levels. Relapse also led to reduced serum albumin and protein levels, increased disease activity, and transient renal impairment. Conclusion: This study underscores the importance of metabolic monitoring in pediatric NS. Persistent lipid abnormalities and protein loss indicate a heightened risk of relapse and long-term cardiovascular and renal complications. Targeted interventions, including lipid-lowering strategies, nephroprotective therapies, and early management of proteinuria, may improve patient outcomes.
Read more